Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1(23)
  2. 10(9)
  3. 10C12(4)
  4. 10F.9G2(23)
  5. 116-13.1(10)
  6. 11B11(20)
  7. 12G5(5)
  8. 14-4-4S(10)
  9. 145-2C11(19)
  10. 15(9)
  11. 15-3-1S(4)
  12. 15A7(4)
  13. 16-10A1(19)
  14. 178 (LALAPG)(5)
  15. 17A2(8)
  16. 18B12(7)
  17. 1a3(5)
  18. 1A8(19)
  19. 1D11.1(5)
  20. 1D11.16.8(10)
  21. 1D3(14)
  22. 1F6(9)
  23. 1G9(26)
  24. 1H1(6)
  25. 2(23)
  26. 2.4G2(19)
  27. 20D5(14)
  28. 20H2(5)
  29. 225(4)
  30. 22D1(19)
  31. 24(5)
  32. 29E.2A3(16)
  33. 29F.1A12(19)
  34. 2D5(10)
  35. 2D5-1.9(9)
  36. 2H7(19)
  37. 3(28)
  38. 30-H12(19)
  39. 33D1(40)
  40. 37(9)
  41. 38(5)
  42. 38/42(4)
  43. 384-35(5)
  44. 3E8#(4)
  45. 3G8(15)
  46. 3H10.1(19)
  47. 3H3(19)
  48. 4(5)
  49. 43(9)
  50. 480(14)
  51. 4A9(18)
  52. 4E1.2(9)
  53. 4LO3311(18)
  54. 50-6(5)
  55. 500A2(20)
  56. 509F6(8)
  57. 51(9)
  58. 53-5.8(19)
  59. 53-6.7(19)
  60. 55R-170(15)
  61. 55R-593(15)
  62. 5C8(3)
  63. 5G11(11)
  64. 6B11(5)
  65. 7B10(15)
  66. 7E.17G9(19)
  67. 7G7B6(19)
  68. 8C8(9)
  69. 9(5)
  70. 9000000000(10)
  71. 927(18)
  72. 9a2(9)
  73. 9D9(19)
  74. 9E9(8)
  75. 9H10(23)
  76. A4C8.1-Do9(10)
  77. A7R34(6)
  78. Abituzumab(3)
  79. Abrilumab(3)
  80. Aducanumab(3)
  81. AF6-88.5(9)
  82. Afasevikumab(3)
  83. AFS98(19)
  84. ALF-161(10)
  85. Amatuximab(3)
  86. Anifrolumab(3)
  87. Anrukinzumab(3)
  88. Apamistamab(3)
  89. Aprutumab(3)
  90. Atezolizumab(3)
  91. Atibuclimab(3)
  92. Avelumab(3)
  93. Avizakimab(3)
  94. B122(10)
  95. B22/249(14)
  96. B6H12(21)
  97. B7/21(5)
  98. B8-24-3(14)
  99. B8.2C12(5)
  100. Bamlanivimab(3)
  101. Bapineuzumab(3)
  102. Basiliximab(3)
  103. Batoclimab(3)
  104. Bavbio(5)
  105. Bavituximab(3)
  106. BC8(19)
  107. BE29G1(15)
  108. Begelomab(3)
  109. Belantamab(3)
  110. Belimumab(3)
  111. Bemarituzumab(3)
  112. Bermekimab(3)
  113. Bersanlimab(3)
  114. Bertilimumab(3)
  115. Bevacizumab(3)
  116. Bexmarilimab(3)
  117. Bimekizumab(3)
  118. Bivatuzumab(3)
  119. Bleselumab(3)
  120. Blosozumab(3)
  121. Bococizumab(3)
  122. Brazikumab(3)
  123. Brentuximab(3)
  124. Briakinumab(3)
  125. Brodalumab(3)
  126. Burosumab(3)
  127. BVD6-24G2(4)
  128. C1.18.4(11)
  129. C17.8(7)
  130. C71/16(16)
  131. C9B7W(18)
  132. Cadbio(5)
  133. Camidanlumab(3)
  134. Camrelizumab(3)
  135. Canakinumab(3)
  136. Caplacizumab(7)
  137. Carlumab(3)
  138. CD28.2(7)
  139. Cedelizumab(3)
  140. Cemiplimab(3)
  141. Cendakimab(3)
  142. Cetuximab(3)
  143. CHK-166(10)
  144. CHK152(5)
  145. Cibbio(5)
  146. Cixutumumab(3)
  147. Clazakizumab(3)
  148. Clenoliximab(3)
  149. Clervonafusp Alfa(4)
  150. Clesrovimab(3)
  151. Codrituzumab(3)
  152. Coltuximab(3)
  153. Cusatuzumab(3)
  154. CXCR3-173(18)
  155. Cy34.1(22)
  156. D12(4)
  157. D5(10)
  158. Dacetuzumab(3)
  159. Daclizumab(3)
  160. Daratumumab(3)
  161. DATK32(15)
  162. Daxdilimab(3)
  163. DC101(14)
  164. Dectrekumab(3)
  165. Denintuzumab(3)
  166. Denosumab(3)
  167. DREG56(5)
  168. Dupilumab(3)
  169. Durvalumab(3)
  170. Dusigitumab(3)
  171. E18(10)
  172. Edrecolomab(3)
  173. Efalizumab(3)
  174. EGFR.1(14)
  175. Eldelumab(3)
  176. Elipovimab(3)
  177. Elotuzumab(3)
  178. Emapalumab(3)
  179. Emibetuzumab(3)
  180. Enfortumab(3)
  181. Enibarcimab(3)
  182. Enoblituzumab(3)
  183. Enokizumab(3)
  184. Epratuzumab(5)
  185. Eptinezumab(3)
  186. Erenumab(3)
  187. ERIC-1(11)
  188. Erlizumab(3)
  189. Etaracizumab(3)
  190. Etokimab(3)
  191. Etrolizumab(3)
  192. Evinacumab(3)
  193. Evolocumab(3)
  194. Faralimomab(3)
  195. Farletuzumab(3)
  196. Fasinumab(3)
  197. FD441.8(15)
  198. Felzartamab(3)
  199. Fezakinumab(3)
  200. FGK4.5(19)
  201. FIB21(9)
  202. FIB27(3)
  203. FIB504(24)
  204. Ficlatuzumab(3)
  205. Figitumumab(3)
  206. Fletikumab(3)
  207. Fontolizumab(3)
  208. Foralumab(3)
  209. FR70(11)
  210. Fremanezumab(3)
  211. Fresolimumab(3)
  212. Frunevetmab(3)
  213. Fulranumab(3)
  214. G11(5)
  215. G28.5(19)
  216. G8.8(14)
  217. Galcanezumab(3)
  218. Gantenerumab(3)
  219. Gatralimab(3)
  220. Gemtuzumab(3)
  221. Gevokizumab(3)
  222. Giloralimab(3)
  223. Gimsilumab(3)
  224. GIR 208(9)
  225. Girentuximab(3)
  226. GK1.5(19)
  227. GL1(14)
  228. GL113(3)
  229. Glembatumumab(3)
  230. Grebio(5)
  231. Guselkumab(3)
  232. H22(20)
  233. H57-597(14)
  234. HB-14(7)
  235. HDB-4A7(9)
  236. HEK/1/85a/7a(18)
  237. HK1.4(10)
  238. HK2.1(15)
  239. HK5.3(15)
  240. HKSP(10)
  241. HKSP84(10)
  242. HM48-1(17)
  243. I21/7(15)
  244. I3/2.3(10)
  245. Ibalizumab(3)
  246. ICRF44(5)
  247. Ieramilimab(3)
  248. Ifibio(5)
  249. Ifinatamab(3)
  250. IK22/5(9)
  251. IM7(19)
  252. Indusatumab(3)
  253. Infliximab(3)
  254. Inolimomab(3)
  255. Intetumumab(3)
  256. Ipilimumab(3)
  257. Iratumumab(3)
  258. Isatuximab(3)
  259. Iscalimab(3)
  260. Itepekimab(3)
  261. Itolizumab(3)
  262. Ivuxolimab(3)
  263. Ixekizumab(3)
  264. J43(4)
  265. JAMA-147(10)
  266. JES5-2A5(4)
  267. JES6-1A12(5)
  268. JES6-5H4(4)
  269. Keliximab(3)
  270. L243(10)
  271. Lacnotuzumab(3)
  272. Lebrikizumab(3)
  273. Lemzoparlimab(3)
  274. Lenzilumab(3)
  275. Lerdelimumab(3)
  276. Lintuzumab(3)
  277. LO-CD2a(4)
  278. Lucatumumab(3)
  279. Lulizumab(3)
  280. Lumiliximab(3)
  281. Lusvertikimab(3)
  282. M1/69(8)
  283. M1/70(15)
  284. M290(4)
  285. M5/114.15.2(18)
  286. M5/49.4.1(10)
  287. Magrolimab(3)
  288. MAR 18.5(18)
  289. MAR1-5A3(19)
  290. Margetuximab(3)
  291. Matuzumab(3)
  292. Mavrilimumab(3)
  293. MB22-11(14)
  294. MD5-1(15)
  295. MECA-367(14)
  296. MECA-89(10)
  297. MEL-14(15)
  298. Metelimumab(3)
  299. Mezagitamab(3)
  300. MFL3(18)
  301. MIB-5E9.1(5)
  302. MIG-2F5-5(18)
  303. Minretumomab(3)
  304. Mirikizumab(3)
  305. Mirvetuximab(3)
  306. Mitazalimab(3)
  307. MJ18(18)
  308. MJ7/18(8)
  309. Monalizumab(3)
  310. Motavizumab(3)
  311. MP1-22E9(19)
  312. MP4-25D2(7)
  313. MP5-20F3(4)
  314. MPC-11(10)
  315. MR1(4)
  316. Mupadolimab(3)
  317. Muromonab(3)
  318. N418(5)
  319. Nadunolimab(3)
  320. Namilumab(3)
  321. Naratuximab(3)
  322. Natalizumab(3)
  323. Naxitamab(3)
  324. Necitumumab(3)
  325. Nemolizumab(3)
  326. Nerelimomab(3)
  327. Nesvacumab(3)
  328. Netakimab(3)
  329. Nipocalimab(3)
  330. Nivolumab(3)
  331. Obexelimab(3)
  332. Ocaratuzumab(3)
  333. Odulimomab(3)
  334. Ofatumumab(3)
  335. OKT-4(19)
  336. OKT10(19)
  337. Oleclumab(3)
  338. Olokizumab(3)
  339. Omalizumab(3)
  340. Omburtamab(3)
  341. Onvatilimab(3)
  342. Otelixizumab(3)
  343. Otilimab(3)
  344. OX-26(18)
  345. OX-7(18)
  346. OX-86(19)
  347. OX-90(18)
  348. Ozanezumab(3)
  349. Ozuriftamab(3)
  350. P84(9)
  351. Palivizumab(3)
  352. Pamrevlumab(3)
  353. Panitumumab(3)
  354. Parsatuzumab(3)
  355. Pascolizumab(3)
  356. Patbio(5)
  357. Pateclizumab(3)
  358. Patritumab(3)
  359. PC61(14)
  360. Pembrolizumab(3)
  361. Penpulimab(3)
  362. Perakizumab(3)
  363. Pertuzumab(3)
  364. Pinatuzumab(3)
  365. Pivekimab(3)
  366. PK136(19)
  367. Polatuzumab(3)
  368. Ponezumab(3)
  369. Ponsegromab(3)
  370. PS/2(18)
  371. Quetmolimab(3)
  372. R1-2(3)
  373. R4-6A2(12)
  374. RA3-6B2(19)
  375. Ramucirumab(3)
  376. Ravagalimab(3)
  377. RB6-8C5(19)
  378. Relatlimab(3)
  379. RG9-1(18)
  380. Rilotumumab(3)
  381. Ripertamab(3)
  382. Rituximab(5)
  383. RM134L(14)
  384. RM27-3E5(23)
  385. RMP1-14(26)
  386. RMP1-14-mAbMods(5)
  387. RMP1-14-mAbMods (D265A)(5)
  388. RMP1-14-mAbMods (LALA-PG)(5)
  389. RMP1-30(6)
  390. RMT1-10(14)
  391. RMT3-23(10)
  392. RMT4-53(10)
  393. Robatumumab(3)
  394. Rolinsatamab(3)
  395. Romosozumab(3)
  396. Rontalizumab(3)
  397. Rosopatamab(3)
  398. Rovalpituzumab(3)
  399. Rozanolixizumab(3)
  400. Sabatolimab(3)
  401. Sacituzumab(3)
  402. Sarilumab(3)
  403. Satralizumab(3)
  404. Secukinumab(3)
  405. Selicrelumab(3)
  406. Sifalimumab(3)
  407. Siltuximab(3)
  408. Simtuzumab(3)
  409. Sintilimab(3)
  410. Siplizumab(3)
  411. Sirukumab(3)
  412. SJ25-C1(6)
  413. Sofituzumab(3)
  414. Sotigalimab(3)
  415. Spesolimab(3)
  416. Sutimlimab(3)
  417. Suvizumab(3)
  418. T24/31(19)
  419. T29/33(5)
  420. T3-3A1(5)
  421. T56/14(5)
  422. TA-99(10)
  423. Tabalumab(3)
  424. Tadocizumab(3)
  425. Tafasitamab(3)
  426. Talbio(5)
  427. TAN1-7(19)
  428. Tanezumab(3)
  429. Tecbio(5)
  430. Teneliximab(3)
  431. Teplizumab(3)
  432. Teprotumumab(3)
  433. Tezepelumab(3)
  434. TIF-3C5(9)
  435. Tilavonemab(3)
  436. Tilvestamab(3)
  437. Tinurilimab(3)
  438. Tiragolumab(3)
  439. Tislelizumab(3)
  440. TKS-1(18)
  441. TN3-19.12(19)
  442. Tocilizumab(3)
  443. Toripalimab(3)
  444. Tositumomab(3)
  445. Tovetumab(3)
  446. TR75-54.7(15)
  447. Tralokinumab(3)
  448. Trastuzumab(3)
  449. Tregalizumab(3)
  450. TRFK5(14)
  451. Tusamitamab(3)
  452. TY/23(25)
  453. TY25(9)
  454. Ublituximab(3)
  455. UC10-4F10-11(19)
  456. UC3-10A6(15)
  457. UC7-13D5(10)
  458. UCHL-1(5)
  459. UCHM-1(5)
  460. UCHT-1(10)
  461. UCHT-2(5)
  462. UCHT-4(5)
  463. Uliledlimab(3)
  464. Upifitamab(3)
  465. Urabrelimab(3)
  466. Urelumab(3)
  467. Ustekinumab(3)
  468. Utomilumab(3)
  469. Vadastuximab(3)
  470. Vanalimab(3)
  471. Varisacumab(3)
  472. Varlilumab(3)
  473. Vatelizumab(3)
  474. Vedolizumab(3)
  475. Veltuzumab(3)
  476. Vibostolimab(3)
  477. Visilizumab(3)
  478. VL-4(10)
  479. Volociximab(3)
  480. Vunakizumab(3)
  481. W6/32(15)
  482. Xentuzumab(3)
  483. XMG1.2(19)
  484. Y-3(15)
  485. Y-3P(10)
  486. YN1/1.7.4(19)
  487. YTS-169(19)
  488. YTS191(18)
  489. Zagotenemab(3)
  490. Zalutumumab(3)
  491. Zanolimumab(3)
  492. Zilovertamab(3)
  493. Ziltivekimab(3)
  494. Zinlirvimab(3)
  495. Zolbetuximab(3)
  496. Zolimomab(3)
  497. ZV67(5)
Applications
Isotype
Hersteller

In Vivo Antibodies

13369 Artikel

pro Seite

Seite:
  1. 103
  2. 104
  3. 105
  4. 106
  5. 107
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Rademikibart Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5271-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Rademikibart Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5271-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Rademikibart Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5271-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Rademikibart Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5271-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Rademikibart Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5271-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Reslizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5272-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Reslizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5272-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Reslizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5272-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Reslizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5272-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Reslizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5272-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Riliprubart Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5273-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Riliprubart Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5273-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Riliprubart Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5273-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Riliprubart Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5273-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Riliprubart Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5273-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Rolistobart Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5274-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Rolistobart Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5274-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Rolistobart Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5274-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Rolistobart Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5274-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Rolistobart Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5274-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Rovelizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5275-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Rovelizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5275-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Rovelizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5275-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Rovelizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5275-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Rovelizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5275-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Name Preis
Rademikibart Biosimilar -­ Research Grade Anmelden Rademikibart Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 10 mg
Lieferbar
Rademikibart Biosimilar -­ Research Grade Anmelden Rademikibart Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Rademikibart Biosimilar -­ Research Grade Anmelden Rademikibart Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 20 mg
Lieferbar
Rademikibart Biosimilar -­ Research Grade Anmelden Rademikibart Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Rademikibart Biosimilar -­ Research Grade Anmelden Rademikibart Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Reslizumab Biosimilar -­ Research Grade Anmelden Reslizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 10 mg
Lieferbar
Reslizumab Biosimilar -­ Research Grade Anmelden Reslizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Reslizumab Biosimilar -­ Research Grade Anmelden Reslizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 20 mg
Lieferbar
Reslizumab Biosimilar -­ Research Grade Anmelden Reslizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Reslizumab Biosimilar -­ Research Grade Anmelden Reslizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Riliprubart Biosimilar -­ Research Grade Anmelden Riliprubart Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 10 mg
Lieferbar
Riliprubart Biosimilar -­ Research Grade Anmelden Riliprubart Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Riliprubart Biosimilar -­ Research Grade Anmelden Riliprubart Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 20 mg
Lieferbar
Riliprubart Biosimilar -­ Research Grade Anmelden Riliprubart Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Riliprubart Biosimilar -­ Research Grade Anmelden Riliprubart Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Rolistobart Biosimilar -­ Research Grade Anmelden Rolistobart Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 10 mg
Lieferbar
Rolistobart Biosimilar -­ Research Grade Anmelden Rolistobart Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Rolistobart Biosimilar -­ Research Grade Anmelden Rolistobart Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 20 mg
Lieferbar
Rolistobart Biosimilar -­ Research Grade Anmelden Rolistobart Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Rolistobart Biosimilar -­ Research Grade Anmelden Rolistobart Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Rovelizumab Biosimilar -­ Research Grade Anmelden Rovelizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 10 mg
Lieferbar
Rovelizumab Biosimilar -­ Research Grade Anmelden Rovelizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Rovelizumab Biosimilar -­ Research Grade Anmelden Rovelizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 20 mg
Lieferbar
Rovelizumab Biosimilar -­ Research Grade Anmelden Rovelizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Rovelizumab Biosimilar -­ Research Grade Anmelden Rovelizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar

13369 Artikel

pro Seite

Seite:
  1. 103
  2. 104
  3. 105
  4. 106
  5. 107
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top